“ What we are trying to do is to get new drugs that are patented into low- and middle-income countries as soon as possible – trying to… ”
In Conversation
“ The industry needs to think ethical by design. Ethics are difficult to sprinkle on top once a technology has already been developed, they need to be… ”
“ A third point of attraction was the Greek ecosystem which although emerging from a recession has a great appetite for fast access to new treatments. The… ”
“ Greece today is an economic wonder with growing GDP, but healthcare expenditure – especially the budget for pharmaceutical medicine – is very low and not increasing… ”
“ Our country has the potential to emerge as a manufacturing and research hub for the wider region of Southeastern Europe ”
“ It is the perfect time for Southern Europe, not only Greece, to play an important role in safeguarding the resilience and stability of the EU in… ”
“ The clawback mechanism is misused. This mechanism was introduced during the crisis to operate as a safety net for potential excess in the budget, and not… ”
“ The COVID-19 pandemic was a good example of why IFET was established and why it remains important. In addition to our work providing orphan drugs and… ”
“ [We have] confidence that we will soon become one of the leading companies not only in Greece but also in Southern Europe ”
“ Regulators, the industry and people in charge of the public healthcare systems are all pushing for regulatory innovation. The European Commission’s (EC) work is interesting because… ”
Michael Himonas – General Manager, Hellenic Association of Pharmaceutical Companies (SFEE), Member of the Board of Directors, EFPIA
“ Unlike other European countries which have capped their clawback system (Portugal) or replaced it with a discount scheme (Romania), the Greek clawback mechanism is out of… ”
“ Greece is the only European country to have included the pharmaceutical industry within its RRF plan, which will allow the inflow of new funds into the… ”